Contact
Autoimmunity & Immunology | Webinars

Uncovering Mechanisms of Immunotherapy Response & Resistance with Single Cell & Spatial Multiomics

22 February 2024
Discover how 10x Genomics' spatial technologies are revolutionising the study of immunotherapies in solid tumors
Watch the full webinar

In this webinar, Abbey Cucthin, Associate Director, Oncology Marketing, discusses how:

  • Visium spatial gene expression uncovers cellular organization within tissue, combining whole transcriptome and targeted protein co-detection with morphological context
  • Xenium in Situ provides subcellular resolution for the characterization of 100s to 1000s of RNAs and multiplexed protein analysis
  • To analyze the role of tertiary lymphoid structures in generating localized anti-tumor immune responses and their association with checkpoint blockade response using spatial technologies
Watch the full webinar

Speaker Biographies

Abbey Cutchin, Associate Director, Oncology Marketing, 10x Genomics

As the oncology marketing lead at 10x Genomics, Abbey Cutchin focuses on developing evidence for using single-cell and spatial multiomics in emerging basic and translational cancer research applications. Previously, Abbey was on the Global Market Development team at Illumina and received her degree in Bioengineering from Stanford.

Related Resources

First Patient Dosed with NK Cell Therapy for the Treatment of an Autoimmune Disease, Lupus Nephritis

The NK cell therapy is being trialled in combination with monoclonal antibody therapy and hopes to induce B-cell depletion.
Read More

Balancing Innovation and Ethics: The Role of Regulation in Microbiome-Based Precision Oncology

Microbiome-based precision oncology offers promising cancer treatment possibilities but requires clear regulations due to ethical concerns like patient safety and access. Collaboration among stakeholders is essential to balance innovation and ethics effectively.
Read More